Portfoliotracker

TriplePoint Venture Growth BDC Corp.

TPVG · NYSE · Finance Správa aktiv 47/100 D

3,780 $
▼ −0,210 (−5,26 %)
Predtrh oneskorené o 20 min
Cena z 16. 11. 22:00, stiahnuté 17. 11. 12:07
Ďalšie výsledky–
Ex-dividenda–
Analytici–
Priemer 50 / 200 dní– / –

Cena

Skóre Portfoliotracker47 / 100 Trhová kapitalizácia154 mil. $ P/E4,4 Forward P/E4,6 P/S3,4 P/B0,5 EV/EBITDA– Dividendový výnos26,46 % FCF výnos-18,91 % Zisk na akciu0,57 $ Čistá marža26,7 % Návratnosť kapitálu ROE6,7 % Beta1,43 Dlh / vlastný kapitál1,17
52-týždňové rozpätie 3,68 až 6,95
Objem za 3 mesiace0,2 mil.

Financie

Kam smerujú tržby

Načítavam tok výkazu ziskov a strát…

Fundamenty

Načítavam kľúčové čísla…

Insideri, analytici a ľudia

Všetky obchody a zmeny

Načítavam insiderov, analytikov a názory…

Co se právě děje

AI souhrn
Objednat AI souhrn, co se u firmy právě děje Vytvoří se jednou na pozadí a pak ho uvidí všichni. Ve verzi Free 3 objednávky měsíčně.

O spoločnosti

TriplePoint Venture Growth BDC Corp. is a business development company specializing investments in venture capital-backed companies at the growth stage investments. It also provides debt financing to venture growth space companies which includes growth capital loans, secured and customized loans, equipment financings, revolving loans and direct equity investments. The fund seeks to invest in e-commerce, entertainment, technology and life sciences sector. Within technology the areas of focus include: Security, wireless communication equipments, network system and software, business applications software, conferencing equipments/services .big data, cloud computing, data storage, electronics, energy efficiency, hardware, information services, internet and media, networking, semiconductors, software, software as a service, and other technology related subsectors and within life sciences the areas of focus include: biotechnology, bio fuels/bio mass, diagnostic testing and bioinformatics, drug delivery, drug discovery, healthcare information systems, healthcare services, medical, surgical and therapeutic devices, pharmaceuticals and other life science related subsectors. Within growth capital loans it invests between $5 million and $50 million, for equipment financings it invests between $5 million and $25 million, for revolving loans it invests between $1 million and $25 million, and for direct equity investments it may invest between $0.1 million and $5 million (generally not exceeding 5% of the company's total equity). The debt financing products are typically structured as lines of credit and it invests through warrants and secured loans. It targeted returns between 10% and 18%. It does not take board seat in the company.

Český popis pripravujeme.

Krajina
USA
Koniec fiškálneho roka
31. 12.
Dáta od
6. 3. 2014

Preskúmajte ďalej

Podobné firmy TSLXTCPCCGBDFDUSNMFC

Graf dňa

Vlastné portfólio, nehnuteľnosti a financie na jednom mieste.

Účet je zadarmo a bez časového obmedzenia. Vaše dáta vidíte len vy, nikto ich nesčíta s ostatnými.

Toto sa ukladá k účtu. Prezerať, počítať a porovnávať môžete ďalej bez prihlásenia.

Vitajte späť

Prihláste sa a pokračujte tam, kde ste skončili.

alebo pokračujte cez

Nemáte účet? Vytvoriť účet zdarma